{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T10:34:38Z","timestamp":1768473278391,"version":"3.49.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","thrombosisresearch.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.thromres.2014.08.018","type":"journal-article","created":{"date-parts":[[2014,8,29]],"date-time":"2014-08-29T19:07:43Z","timestamp":1409339263000},"page":"963-969","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["CVD risk factors are related to plasma fibrin clot properties independent of total and or \u03b3\u2019 fibrinogen concentration"],"prefix":"10.1016","volume":"134","author":[{"given":"Retha C.M.","family":"Kotz\u00e9","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.S.","family":"Ari\u00ebns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zelda","family":"de Lange","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlien","family":"Pieters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.thromres.2014.08.018_bb0005","doi-asserted-by":"crossref","first-page":"e48881","DOI":"10.1371\/journal.pone.0048881","article-title":"Plasma clot lysis time and its association with cardiovascular risk factors in black Africans","volume":"7","author":"De Lange","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.thromres.2014.08.018_bb0010","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1055\/s-0038-1650618","article-title":"Proneness to formation of tight and rigid fibrin gel structures in men with myocardial infarction at a young age","volume":"76","author":"Fatah","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2014.08.018_bb0015","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1161\/STROKEAHA.108.532812","article-title":"Altered fibrin clot structure\/function in patients with cryptogenic ischemic stroke","volume":"40","author":"Undas","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.thromres.2014.08.018_bb0020","doi-asserted-by":"crossref","first-page":"4272","DOI":"10.1182\/blood-2009-05-222380","article-title":"Altered fibrin clot structure\/function in patients with idiopathic venous thromboembolism and in their relatives","volume":"114","author":"Undas","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2014.08.018_bb0025","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1161\/ATVBAHA.111.230631","article-title":"Fibrin clot structure and function: a role in the pathophysiology of arterial and venous thromboembolic diseases","volume":"31","author":"Undas","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"Suppl. 1","key":"10.1016\/j.thromres.2014.08.018_bb0030","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1538-7836.2007.02504.x","article-title":"Structure of fibrin: impact on clot stability","volume":"5","author":"Weisel","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2014.08.018_bb0035","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1161\/ATVBAHA.111.236786","article-title":"Clot architecture is altered in abdominal aortic aneurysms and correlates with aneurysm size","volume":"31","author":"Scott","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.thromres.2014.08.018_bb0040","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.bpc.2004.07.029","article-title":"The mechanical properties of fibrin for basic scientists and clinicians","volume":"112","author":"Weisel","year":"2004","journal-title":"Biophys Chem"},{"key":"10.1016\/j.thromres.2014.08.018_bb0045","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1161\/ATVBAHA.107.153221","article-title":"Heritability of clot formation, morphology, and lysis; the EuroCLOT study","volume":"27","author":"Carter","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.thromres.2014.08.018_bb0050","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.atherosclerosis.2007.05.028","article-title":"Reduced clot permeability and susceptibility to lysis in patients with acute coronary syndrome: effects of inflammation and oxidative stress","volume":"196","author":"Undas","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.thromres.2014.08.018_bb0055","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0049-3848(91)90109-A","article-title":"Studies on fibrin network structure: the effect of some plasma proteins","volume":"61","author":"Nair","year":"1991","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2014.08.018_bb0060","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1182\/blood-2002-08-2527","article-title":"Elevated prothrombin results in clots with an altered fibre structure: a possible mechanism of the increased thrombotic risk","volume":"101","author":"Wolberg","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2014.08.018_bb0065","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1182\/blood-2008-03-145755","article-title":"Polyphosphate enhances fibrin clot structure","volume":"112","author":"Smith","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2014.08.018_bb0070","doi-asserted-by":"crossref","first-page":"3942","DOI":"10.1182\/blood-2011-03-339572","article-title":"Factor XIIa regulates the structure of the fibrin clot independently of thrombin generation through direct interaction with fibrin","volume":"118","author":"Konings","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2014.08.018_bb0075","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0021-9258(18)55978-0","article-title":"Effects of ions and neutral molecules on fibrin clotting","volume":"191","author":"Edsall","year":"1951","journal-title":"J Biol Chem"},{"key":"10.1016\/j.thromres.2014.08.018_bb0080","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/jth.12455","article-title":"The effect of blood coagulation factor XIII on fibrin clot structure and fibrinolysis","volume":"12","author":"Hethershaw","year":"2014","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2014.08.018_bb0085","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1160\/TH13-10-0855","article-title":"Roles of fibrin \u03b1- and \u03b3-chain specific cross-linking by FXIIIa in fibrin structure and function","volume":"111","author":"Duval","year":"2014","journal-title":"Thromb Haemost"},{"issue":"Suppl. 1","key":"10.1016\/j.thromres.2014.08.018_bb0090","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/jth.12229","article-title":"Fibrin(ogen) and thrombotic disease","volume":"11","author":"Ari\u00ebns","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2014.08.018_bb0095","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1161\/01.CIR.0000033221.73082.06","article-title":"Altered fibrin clot structure in the healthy relatives of patients with premature coronary artery disease","volume":"106","author":"Mills","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2014.08.018_bb0100","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1182\/blood-2012-12-471482","article-title":"Evidence that fibrinogen \u03b3\u2019 regulates plasma clot structure and lysis and relationship to cardiovascular risk factors in black Africans","volume":"121","author":"Pieters","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2014.08.018_bb0105","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0006-3495(92)81594-1","article-title":"Computer modeling of fibrin polymerization kinetics correlated with electron microscope and turbidity observations: clot structure and assembly are kinetically controlled","volume":"63","author":"Weisel","year":"1992","journal-title":"Biophys J"},{"key":"10.1016\/j.thromres.2014.08.018_bb0110","doi-asserted-by":"crossref","first-page":"4854","DOI":"10.1182\/blood-2007-08-105247","article-title":"Dynamic imaging of fibrin network formation correlated with other measures of polymerization","volume":"111","author":"Chernysh","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2014.08.018_bb0115","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1182\/blood-2012-08-451518","article-title":"Visualization of the dynamics of fibrin clot growth 1 molecule at a time by total internal reflection fluorescence microscopy","volume":"121","author":"Hategan","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2014.08.018_bb0120","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.thromres.2008.11.016","article-title":"The presence of \u03b3\u2032 chain impairs fibrin polymerization","volume":"124","author":"Gersh","year":"2009","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2014.08.018_bb0125","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1111\/j.1538-7836.2012.04717.x","article-title":"Evidence that fibrinogen \u03b3\u2019 directly interferes with protofibril growth: implications for fibrin structure and clot stiffness","volume":"10","author":"Allan","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2014.08.018_bb0130","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1160\/TH11-03-0192","article-title":"Fibrinogen concentration and its role in CVD risk in black South Africans \u2013 effect of urbanisation","volume":"106","author":"Pieters","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2014.08.018_bb0135","doi-asserted-by":"crossref","first-page":"956","DOI":"10.7326\/0003-4819-118-12-199306150-00008","article-title":"Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature","volume":"118","author":"Ernst","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.thromres.2014.08.018_bb0140","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1161\/01.CIR.102.14.1634","article-title":"Association of fibrinogen with cardiovascular risk factors and cardiovascular disease in the Framingham offspring population","volume":"102","author":"Stec","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2014.08.018_bb0145","first-page":"341","article-title":"The past decade: fibrinogen","volume":"29","author":"Pulani\u0107","year":"2005","journal-title":"Coll Antropol"},{"key":"10.1016\/j.thromres.2014.08.018_bb0150","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1055\/s-0030-1248720","article-title":"Fibrinogen and the risk of thrombosis","volume":"36","author":"De Moerloose","year":"2010","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.thromres.2014.08.018_bb0155","first-page":"1","article-title":"Is fibrinogen a marker of inflammation in coronary artery disease?","volume":"51","author":"Papageorgiou","year":"2010","journal-title":"Hellenic J Cardiol"},{"key":"10.1016\/j.thromres.2014.08.018_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1748-1716.2009.02037.x","article-title":"Mechanisms of fibrinogen-induced microvascular dysfunction during cardiovascular disease","volume":"198","author":"Lominadze","year":"2010","journal-title":"Acta Physiol (Oxf)"},{"key":"10.1016\/j.thromres.2014.08.018_bb0165","doi-asserted-by":"crossref","first-page":"4176","DOI":"10.1182\/blood-2005-05-2180","article-title":"Genetic variation in the fibrinogen gamma gene increases the risk for deep venous thrombosis by reducing plasma fibrinogen \u03b3\u2019 levels","volume":"106","author":"Uitte de Willige","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2014.08.018_bb0170","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1182\/blood-2004-08-3253","article-title":"Reduced plasma fibrinolytic potential is a risk factor for venous thrombosis","volume":"105","author":"Lisman","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2014.08.018_bb0175","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1160\/TH12-02-0124","article-title":"Biological variation in tPA-induced plasma clot lysis time","volume":"108","author":"Talens","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2014.08.018_bb0180","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1182\/blood-2009-08-237719","article-title":"Residual platelet factor V ensures thrombin generation in patients with severe congenital factor V deficiency and mild bleeding symptoms","volume":"115","author":"Duckers","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2014.08.018_bb0185","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc B"},{"key":"10.1016\/j.thromres.2014.08.018_bb0190","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.exger.2007.06.014","article-title":"Hemostasis factors and aging","volume":"43","author":"Mari","year":"2008","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.thromres.2014.08.018_bb0195","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1055\/s-2002-36700","article-title":"Aging and thrombosis","volume":"28","author":"Wilkerson","year":"2002","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.thromres.2014.08.018_bb0200","first-page":"120","article-title":"Risk factors for venous and arterial thrombosis","volume":"9","author":"Previtali","year":"2011","journal-title":"Blood Transfus"},{"key":"10.1016\/j.thromres.2014.08.018_bb0205","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1046\/j.1538-7836.2003.00242.x","article-title":"The role of recombinant factor VIIa (FVIIa) in fibrin structure in the absence of FVIII\/FIX","volume":"1","author":"He","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2014.08.018_bb0210","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-2141.2005.05820.x","article-title":"High dose factor VIIa improves clot structure and stability in a model of haemophilia B","volume":"131","author":"Wolberg","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.thromres.2014.08.018_bb0215","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2174\/187152508784871963","article-title":"The biochemical and physical process of fibrinolysis and effects of clot structure and stability on the lysis rate","volume":"6","author":"Weisel","year":"2008","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"key":"10.1016\/j.thromres.2014.08.018_bb0220","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1182\/blood-2007-06-096545","article-title":"Venous thrombosis in the elderly: more questions than answers","volume":"110","author":"Silverstein","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2014.08.018_bb0225","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1160\/TH06-12-0715","article-title":"Fibrin clot structure in patients with end-stage renal disease","volume":"98","author":"Sj\u00f8land","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2014.08.018_bb0230","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3177\/jnsv.53.37","article-title":"Relationship between serum albumin level and aging in community-dwelling self-supported elderly population","volume":"53","author":"Gomi","year":"2007","journal-title":"J Nutr Sci Vitaminol"},{"key":"10.1016\/j.thromres.2014.08.018_bb0235","first-page":"107","article-title":"Serum albumin and prevalence of coronary heart disease","volume":"13","author":"H\u00f8stmark","year":"2003","journal-title":"Nor Epidemiol"},{"key":"10.1016\/j.thromres.2014.08.018_bb0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0167-4943(84)90011-6","article-title":"Modifications of fibronectin in age-related diseases: diabetes and cancer","volume":"3","author":"Labat-Robert","year":"1984","journal-title":"Arch Gerontol Geriatr"},{"issue":"8","key":"10.1016\/j.thromres.2014.08.018_bb0245","doi-asserted-by":"crossref","first-page":"e41966","DOI":"10.1371\/journal.pone.0041966","article-title":"Identification of fibrin clot-bound plasma proteins","volume":"7","author":"Talens","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.thromres.2014.08.018_bb0250","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s11239-009-0433-0","article-title":"Age-related changes in fibrin networks and platelets of individuals over 75: a scanning electron microscopy study showing \u201cthrombotic preparedness\u201d","volume":"29","author":"Pretorius","year":"2010","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.thromres.2014.08.018_bb0255","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1093\/aje\/152.10.897","article-title":"Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome","volume":"152","author":"Sakkinen","year":"2000","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.thromres.2014.08.018_bb0260","first-page":"241","article-title":"Insulin resistance syndrome: interaction with coagulation and fibrinolysis","volume":"132","author":"Kohler","year":"2002","journal-title":"Swiss Med Wkly"},{"issue":"1","key":"10.1016\/j.thromres.2014.08.018_bb0265","article-title":"Risk-factor profiles for chronic diseases of lifestyle and metabolic syndrome in an urban and rural setting in South Africa","volume":"4","author":"Van Zyl","year":"2012","journal-title":"Afr J Prm Health Care Fam Med"},{"key":"10.1016\/j.thromres.2014.08.018_bb0270","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/jth.12125","article-title":"Oxidized high-density lipoprotein reduces blood clot firmness","volume":"11","author":"Talens","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2014.08.018_bb0275","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1161\/01.ATV.12.12.1516","article-title":"Increased lipid binding to thrombi in coronary artery disease. Findings in patients without premedication in native (not anticoagulated) test systems","volume":"12","author":"Kunz","year":"1992","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.thromres.2014.08.018_bb0280","doi-asserted-by":"crossref","first-page":"365","DOI":"10.4330\/wjc.v2.i11.365","article-title":"Linking inflammation and thrombosis: role of C-reactive protein","volume":"2","author":"Fay","year":"2010","journal-title":"World J Cardiol"},{"key":"10.1016\/j.thromres.2014.08.018_bb0285","doi-asserted-by":"crossref","first-page":"e251","DOI":"10.1016\/j.thromres.2012.03.014","article-title":"Monomeric C-reactive protein alters fibrin clot properties on endothelial cells","volume":"129","author":"Li","year":"2012","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2014.08.018_bb0290","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/S0021-9258(17)43435-1","article-title":"Binding of fibronectin by the acute phase reactant C-reactive protein","volume":"259","author":"Salonen","year":"1984","journal-title":"J Biol Chem"},{"key":"10.1016\/j.thromres.2014.08.018_bb0295","doi-asserted-by":"crossref","first-page":"363","DOI":"10.7326\/0003-4819-131-5-199909070-00008","article-title":"Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence","volume":"131","author":"Eikelboom","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.thromres.2014.08.018_bb0300","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1161\/01.ATV.0000219688.43572.75","article-title":"Plasma homocysteine affects fibrin clot permeability and resistance to lysis in human subjects","volume":"26","author":"Undas","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.thromres.2014.08.018_bb0305","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1111\/j.1538-7836.2007.02637.x","article-title":"Altered fibrin clot structure in patients with advanced coronary artery disease: a role of C-reactive protein, lipoprotein(a) and homocysteine","volume":"5","author":"Undas","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2014.08.018_bb0310","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0049-3848(02)00191-3","article-title":"Effects of homocysteine thiol group on fibrin networks: another possible mechanism of harm","volume":"107","author":"Lauricella","year":"2002","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2014.08.018_bb0315","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1160\/TH07-06-0404","article-title":"Comparison of the effect of different homocysteine concentrations on clot formation using human plasma and purified fibrinogen","volume":"99","author":"Marchi","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2014.08.018_bb0320","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.thromres.2010.11.027","article-title":"Comparison of the effect of homocysteine in the reduced form, its thiolactone and protein homocysteinylation on hemostatic properties of plasma","volume":"127","author":"Malinowska","year":"2011","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2014.08.018_bb0325","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1021\/bi052076j","article-title":"Modification of fibrinogen by homocysteine thiolactone increases resistance to fibrinolysis: a potential mechanism of the thrombotic tendency in hyperhomocysteinemia","volume":"45","author":"Sauls","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.thromres.2014.08.018_bb0330","doi-asserted-by":"crossref","first-page":"623","DOI":"10.33549\/physiolres.931566","article-title":"Mechanism of action of homocysteine and its thiolactone in hemostasis system","volume":"58","author":"Karolczak","year":"2009","journal-title":"Physiol Res"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004938481400454X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004938481400454X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,2]],"date-time":"2024-06-02T03:06:09Z","timestamp":1717297569000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004938481400454X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":66,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S004938481400454X"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2014.08.018","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CVD risk factors are related to plasma fibrin clot properties independent of total and or \u03b3\u2019 fibrinogen concentration","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2014.08.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}